Techcyte Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 121

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $15M

  • Investors
  • 6

Techcyte General Information

Description

Developer of a first cloud-based digital pathology platform designed to support both anatomic and clinical pathology. The company's platform consists of workflow and AI (Artificial Intelligence) to help labs with the efficiency and accuracy of their diagnostic testing, its technology uses deep learning image analysis and is HIPAA compliant, CE marked, enabling support tests across histology, hematology, cytology, bacteriology, and parasitology, providing human, veterinary, and environmental clinics and labs with AI-powered digital diagnostics tools.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1106 North 1200 West
  • Orem, UT 84057
  • United States
+1 (801)
Primary Industry
Decision/Risk Analysis
Other Industries
Automation/Workflow Software
Business/Productivity Software
Enterprise Systems (Healthcare)
Corporate Office
  • 1106 North 1200 West
  • Orem, UT 84057
  • United States
+1 (801)

Techcyte Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Techcyte Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC 30-Apr-2026 $15M Completed Generating Revenue
9. Later Stage VC (Series F) 01-Oct-2024 Completed Generating Revenue
8. Later Stage VC (Series E) 18-Aug-2021 Completed Generating Revenue
7. Debt - PPP 15-Apr-2020 Completed Generating Revenue
6. Later Stage VC (Series D) 01-Feb-2019 Completed Generating Revenue
5. Later Stage VC (Series C) 01-Jul-2017 Completed Startup
4. Early Stage VC (Series B) 01-Feb-2016 Completed Startup
3. Accelerator/Incubator Completed Startup
2. Early Stage VC (Series A) 01-Nov-2013 $113K $113K Completed Startup
1. University Spin-Out 01-Jul-2013 Completed Startup
To view Techcyte’s complete valuation and funding history, request access »

Techcyte Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series F
Series E
Series D
Series C
Series B 3,760,304 10% $0.25 $0.25 1x $0.25 8.9%
Series A 3,775,405 10% $3 $3 1x $3 8.93%
To view Techcyte’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Techcyte Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a first cloud-based digital pathology platform designed to support both anatomic and clinical pathology. Th
Decision/Risk Analysis
Orem, UT
121 As of 2026

Philadelphia, PA
 

Spokane, WA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Techcyte Competitors (12)

One of Techcyte’s 12 competitors is Proscia, a Formerly VC-backed company based in Philadelphia, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Proscia Formerly VC-backed Philadelphia, PA
Gestalt (Decision/Risk Analysis) Venture Capital-Backed Spokane, WA
Lumea (Decision/Risk Analysis) Corporation Lehi, UT
Datexim Venture Capital-Backed Caen, France
PathPresenter Venture Capital-Backed Montville, NJ
You’re viewing 5 of 12 competitors. Get the full list »

Techcyte Patents

Techcyte Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12586198-B2 Image analysis for identifying objects and classifying background exclusions Active 18-Feb-2022
US-20230281819-A1 Image analysis for identifying objects and classifying background exclusions Active 18-Feb-2022
US-20260311477-A1 Neural network training protocol for automated image analysis for classifying foreground and background regions Pending 18-Feb-2022
EP-4370933-A2 Image analysis for classifying hemagglutination and quantifying presence of antibodies Inactive 15-Jul-2021
EP-4370933-A4 Image analysis for classifying hemagglutination and quantifying presence of antibodies Inactive 15-Jul-2021 G01N33/5304
To view Techcyte’s complete patent history, request access »

Techcyte Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Techcyte Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Mayo Clinic Corporation Minority
Van Tuyl Companies Family Office Minority
ARUP Laboratories Corporation Minority
Zoetis Corporation Minority
Atomic (Private Equity) Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Techcyte FAQs

  • When was Techcyte founded?

    Techcyte was founded in 2013.

  • Where is Techcyte headquartered?

    Techcyte is headquartered in Orem, UT.

  • What is the size of Techcyte?

    Techcyte has 121 total employees.

  • What industry is Techcyte in?

    Techcyte’s primary industry is Decision/Risk Analysis.

  • Is Techcyte a private or public company?

    Techcyte is a Private company.

  • What is Techcyte’s current revenue?

    The current revenue for Techcyte is .

  • How much funding has Techcyte raised over time?

    Techcyte has raised $51.4M.

  • Who are Techcyte’s investors?

    Mayo Clinic, Van Tuyl Companies, ARUP Laboratories, Zoetis, and Atomic (Private Equity) are 5 of 6 investors who have invested in Techcyte.

  • Who are Techcyte’s competitors?

    Proscia, Gestalt (Decision/Risk Analysis), Lumea (Decision/Risk Analysis), Datexim, and PathPresenter are some of the 12 competitors of Techcyte.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process